200 related articles for article (PubMed ID: 32776284)
1. Different effects of tryptophan 2,3-dioxygenase inhibition on SK-Mel-28 and HCT-8 cancer cell lines.
Paccosi S; Cecchi M; Silvano A; Fabbri S; Parenti A
J Cancer Res Clin Oncol; 2020 Dec; 146(12):3155-3163. PubMed ID: 32776284
[TBL] [Abstract][Full Text] [Related]
2. Dexamethasone Induces the Expression and Function of Tryptophan-2-3-Dioxygenase in SK-MEL-28 Melanoma Cells.
Cecchi M; Paccosi S; Silvano A; Eid AH; Parenti A
Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33806305
[TBL] [Abstract][Full Text] [Related]
3. IDO1/TDO dual inhibitor RY103 targets Kyn-AhR pathway and exhibits preclinical efficacy on pancreatic cancer.
Liang H; Li T; Fang X; Xing Z; Zhang S; Shi L; Li W; Guo L; Kuang C; Liu H; Yang Q
Cancer Lett; 2021 Dec; 522():32-43. PubMed ID: 34520819
[TBL] [Abstract][Full Text] [Related]
4. Unveiling the Role of Tryptophan 2,3-Dioxygenase in the Angiogenic Process.
Cecchi M; Anceschi C; Silvano A; Coniglio ML; Chinnici A; Magnelli L; Lapucci A; Laurenzana A; Parenti A
Pharmaceuticals (Basel); 2024 Apr; 17(5):. PubMed ID: 38794128
[TBL] [Abstract][Full Text] [Related]
5. Tryptophan 2,3-Dioxygenase Expression Identified in Murine Decidual Stromal Cells Is Not Essential for Feto-Maternal Tolerance.
Hoffmann D; Dvorakova T; Schramme F; Stroobant V; Van den Eynde BJ
Front Immunol; 2020; 11():601759. PubMed ID: 33363543
[TBL] [Abstract][Full Text] [Related]
6. Indoleamine dioxygenase and tryptophan dioxygenase activities are regulated through GAPDH- and Hsp90-dependent control of their heme levels.
Biswas P; Dai Y; Stuehr DJ
Free Radic Biol Med; 2022 Feb; 180():179-190. PubMed ID: 35051612
[TBL] [Abstract][Full Text] [Related]
7. Dexamethasone Promotes a Stem-Like Phenotype in Human Melanoma Cells
Cecchi M; Mannini A; Lapucci A; Silvano A; Lulli M; Luceri C; D'Ambrosio M; Chiarugi A; Eid AH; Parenti A
Front Pharmacol; 2022; 13():911019. PubMed ID: 35847038
[TBL] [Abstract][Full Text] [Related]
8. Tryptophan degradation enzymes and Angiotensin (1-7) expression in human placenta.
Silvano A; Seravalli V; Strambi N; Tartarotti E; Tofani L; Calosi L; Parenti A; Di Tommaso M
J Reprod Immunol; 2022 Sep; 153():103692. PubMed ID: 35970080
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of indole-2-carboxylic acid derivatives as IDO1/TDO dual inhibitors.
Cui G; Lai F; Wang X; Chen X; Xu B
Eur J Med Chem; 2020 Feb; 188():111985. PubMed ID: 31881488
[TBL] [Abstract][Full Text] [Related]
10. Evaluation and comparison of the commonly used bioassays of human indoleamine 2,3-dioxygenase 1 (IDO1) and tryptophan 2,3-dioxygenase (TDO).
Zhang S; Guo L; Yang D; Xing Z; Li W; Kuang C; Yang Q
Bioorg Chem; 2020 Nov; 104():104348. PubMed ID: 33142415
[TBL] [Abstract][Full Text] [Related]
11. A comprehensive comparison of the metazoan tryptophan degrading enzymes.
Yuasa HJ
Biochim Biophys Acta Proteins Proteom; 2020 Jan; 1868(1):140247. PubMed ID: 31276825
[TBL] [Abstract][Full Text] [Related]
12. Both IDO1 and TDO contribute to the malignancy of gliomas via the Kyn-AhR-AQP4 signaling pathway.
Du L; Xing Z; Tao B; Li T; Yang D; Li W; Zheng Y; Kuang C; Yang Q
Signal Transduct Target Ther; 2020 Feb; 5(1):10. PubMed ID: 32296044
[TBL] [Abstract][Full Text] [Related]
13. Targeting Indoleamine Dioxygenase and Tryptophan Dioxygenase in Cancer Immunotherapy: Clinical Progress and Challenges.
Peng X; Zhao Z; Liu L; Bai L; Tong R; Yang H; Zhong L
Drug Des Devel Ther; 2022; 16():2639-2657. PubMed ID: 35965963
[TBL] [Abstract][Full Text] [Related]
14. Role of indoleamine 2,3-dioxygenase in testicular immune-privilege.
Gualdoni GS; Jacobo PV; Sobarzo CM; Pérez CV; Matzkin ME; Höcht C; Frungieri MB; Hill M; Anegon I; Lustig L; Guazzone VA
Sci Rep; 2019 Nov; 9(1):15919. PubMed ID: 31685866
[TBL] [Abstract][Full Text] [Related]
15. Discovery and biological evaluation of tanshinone derivatives as potent dual inhibitors of indoleamine 2, 3-dioxygenase 1 and tryptophan 2, 3-dioxygenase.
Liu J; Ren J; Yang K; Chen S; Yang X; Zhao QS
Eur J Med Chem; 2022 May; 235():114294. PubMed ID: 35358772
[TBL] [Abstract][Full Text] [Related]
16. 4,6-Substituted-1H-Indazoles as potent IDO1/TDO dual inhibitors.
Yang L; Chen Y; He J; Njoya EM; Chen J; Liu S; Xie C; Huang W; Wang F; Wang Z; Li Y; Qian S
Bioorg Med Chem; 2019 Mar; 27(6):1087-1098. PubMed ID: 30773421
[TBL] [Abstract][Full Text] [Related]
17. Diaryl hydroxylamines as pan or dual inhibitors of indoleamine 2,3-dioxygenase-1, indoleamine 2,3-dioxygenase-2 and tryptophan dioxygenase.
Winters M; DuHadaway JB; Pham KN; Lewis-Ballester A; Badir S; Wai J; Sheikh E; Yeh SR; Prendergast GC; Muller AJ; Malachowski WP
Eur J Med Chem; 2019 Jan; 162():455-464. PubMed ID: 30469041
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of novel tryptanthrin derivatives as dual inhibitors of indoleamine 2,3-dioxygenase 1 and tryptophan 2,3-dioxygenase.
Li Y; Zhang S; Wang R; Cui M; Liu W; Yang Q; Kuang C
Bioorg Med Chem Lett; 2020 Jun; 30(11):127159. PubMed ID: 32247733
[TBL] [Abstract][Full Text] [Related]
19. Efficient tryptophan-catabolizing activity is consistently conserved through evolution of TDO enzymes, but not IDO enzymes.
Yuasa HJ; Ball HJ
J Exp Zool B Mol Dev Evol; 2015 Mar; 324(2):128-40. PubMed ID: 25702628
[TBL] [Abstract][Full Text] [Related]
20. Identification and Characterization of a Novel Dual Inhibitor of Indoleamine 2,3-dioxygenase 1 and Tryptophan 2,3-dioxygenase.
Yoshioka S; Ikeda T; Fukuchi S; Kawai Y; Ohta K; Murakami H; Ogo N; Muraoka D; Takikawa O; Asai A
Int J Tryptophan Res; 2022; 15():11786469221138456. PubMed ID: 36467776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]